Rakha et al. [41] examined seventeen BRCA1-associated ER-, HER2- breast cancers and found that only one of seventeen (5.9%) did not show expression of either CK5/6 or EGFR, also considered to be a basal marker. Here, ERBB2 is linked to breast carcinoma.